{"id":"W4407248544","doi":"10.1136/bmjopen-2024-092032","title":"Trial protocol of an open-label pilot study of oral naltrexone–bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)","year":2025,"lang":"en","type":"article","venue":"BMJ Open","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"National Centre for Clinical Research on Emerging Drugs; National Center for Advancing Translational Sciences; National Institute of Mental Health; National Health and Medical Research Council; National Institute on Drug Abuse; Substance Abuse and Mental Health Services Administration; Otsuka Pharmaceutical; Daiichi Sankyo Europe; Indivior; Department of Health and Aged Care, Australian Government; ACADIA Pharmaceuticals; University of Oxford; Medical Research Council; Biogen; American Foundation for Suicide Prevention; Otsuka America; Neurocrine Biosciences; Patient-Centered Outcomes Research Institute; Sage Therapeutics","keywords":"Medicine; Bupropion; Clinical trial; Naltrexone; Psychiatry; Randomized controlled trial; Adverse effect; Clinical endpoint; Psychosocial; Internal medicine; Smoking cessation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04451847,0.005091848,0.006963439,0.00155972,0.004544664,0.003344313,0.003840903,0.00834223,0.09828714],"category_scores_gemma":[0.03177059,0.002816051,0.003081274,0.002102013,0.004019877,0.004236605,0.002312474,0.009918571,0.02579262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004027624,"about_ca_system_score_gemma":0.02007732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00133454,"about_ca_topic_score_gemma":0.003944779,"domain_scores_codex":[0.9756352,0.01545796,0.002429314,0.00222463,0.002341238,0.001911803],"domain_scores_gemma":[0.9804038,0.004053243,0.003311178,0.003277787,0.004408465,0.00454546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8536301,0.02470403,0.001163494,0.01471498,0.000930277,0.0006099964,0.000765789,0.00141883,0.003294054,0.008103902,0.04042541,0.05023911],"study_design_scores_gemma":[0.8431435,0.06559961,0.002599836,0.00306236,0.0004372485,0.0001710892,0.0002208316,0.001568369,0.0009859693,0.003898141,0.07817005,0.0001430788],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.001329656,0.0001745429,0.001054486,0.0002718775,0.0004188696,0.9950223,0.0008401927,0.00005063639,0.0008375128],"genre_scores_gemma":[0.002190702,0.0001306271,0.001556201,0.000318485,0.0001358105,0.9948398,0.0002234456,0.000005053018,0.0005999445],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.09828714,"threshold_uncertainty_score":0.3288032,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.321238782884704,"score_gpt":0.532371197770204,"score_spread":0.2111324148855,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}